Table II.
Association between AFAP1-AS1 expression level and clinicopathological characteristics of patients.
| AFAP1-AS1 expression | |||||
|---|---|---|---|---|---|
| AFAP1-AS1 | |||||
| Factors | Number | High (n=33) | Low (n=33) | χ2 | P-value |
| Age, years | 0.092 | 0.319 | |||
| <60 | 28 | 12 | 16 | ||
| ≥60 | 38 | 21 | 17 | ||
| Sex distribution | 1.746 | 0.186 | |||
| Female | 21 | 8 | 13 | ||
| Male | 45 | 25 | 20 | ||
| Family history | 1.610 | 0.205 | |||
| Positive | 25 | 15 | 10 | ||
| Negative | 41 | 18 | 23 | ||
| Ulceration | 0.262 | 0.609 | |||
| Positive | 24 | 12 | 11 | ||
| Negative | 42 | 20 | 22 | ||
| Tumor size, cm | 3.970 | 0.046 | |||
| <2 | 38 | 15 | 23 | ||
| ≥2 | 28 | 18 | 10 | ||
| Clinical stage | 10.882 | 0.001 | |||
| I–II | 41 | 14 | 27 | ||
| III–IV | 25 | 19 | 6 | ||
| Differentiation | 11.643 | 0.003 | |||
| Well | 22 | 5 | 17 | ||
| Moderate | 27 | 15 | 12 | ||
| Poor | 17 | 13 | 4 | ||
AFAP1-AS1, AFAP1-antisense RNA 1; n, number.